Targeting infections within the gastrointestinal tract

Hannah Batchelor, Barbara Conway

Research output: Chapter in Book/Report/Conference proceedingChapter

4 Citations (Scopus)

Abstract

Pharmaceuticals remain the least invasive and most cost-effective means of patient treatment, and represent a substantially important factor in the potential reductionof long-term, overall healthcare costs. The pharmaceutical industry continues to evolve within a transitional environment as most of the elements affecting its core business have changed. Drug companies are confronting the consequences of managed care, increased pricing pressures, generic competition, and overall margin shrinkage. In response, they are vigorously seeking new ways to increase profitability, differentiate their products, and add depth and diversity to their product lines. One of these alternatives is to exploit improvements upon the method of drug delivery.

Original languageEnglish
Title of host publicationAdvanced Drug Formulation Design to Optimize Therapeutic Outcomes
EditorsRobert O. Williams III, David R. Taft, Jason T. McConville
PublisherCRC Press
Chapter7
Pages217-244
Number of pages28
ISBN (Electronic)9781420043884
ISBN (Print)9781420043877
Publication statusPublished - 25 Sep 2007
Externally publishedYes

Publication series

NameDrugs and the Pharmaceutical Series

Fingerprint Dive into the research topics of 'Targeting infections within the gastrointestinal tract'. Together they form a unique fingerprint.

Cite this